Big Pharma paid millions of dollars to members of the US Senate Finance Committee, which will cast the first vote on Robert F. Kennedy’s nomination as head of Health and Human Services.
Analysis by The Federalist revealed individual payments of hundreds of thousands of dollars to Committee members.
“Republicans overall brought in nearly $5 million from the pharmaceutical industry across 13 members while Democrats raised more than $1.7 million across 9,” according to The Federalist.
The Committee, which will have a Republican majority under the new Trump administration, will vote to confirm Kennedy in January.
Between 2019 and 2024, Big Pharma contributed over $6.7 million to members of the Senate Finance Committee. […]
— Read More: www.infowars.com
